What is the current stock price of Crossject S.A. (ALCJ.PA)?

As of the latest market data, Crossject S.A. (ALCJ.PA) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Crossject S.A. (ALCJ.PA) pay a dividend?

Based on current data, Crossject S.A. does not have a confirmed active dividend policy.

What is the market cap of Crossject S.A.?

The current market capitalization of Crossject S.A. (ALCJ.PA) is approximately unavailable.

ALCJ.PA

Crossject S.A.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

112

IPO Date

2014-02-20

Beta

0.52

Websitewww.crossject.com↗